Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion
Rhea-AI Summary
Kraig Biocraft Laboratories (OTCQB: KBLB) announced on Dec 8, 2025 that it has been granted usage rights to a block of government-owned mulberry gardens near its Southeast Asia spider silk production facilities. The company will pay a nominal rent and will incorporate the gardens into its production pipeline to supply mulberry leaf feedstock for scaled-up recombinant spider silk manufacturing, including BAM-1 Alpha hybrid yarns.
This land access is intended to improve supply reliability, logistics, and the company's ability to support a recently announced pilot order from a leading performance sports apparel brand as Kraig Labs advances toward broader commercialization.
Positive
- Granted usage rights to government-owned mulberry gardens to support production
- Direct feedstock source to support scaled-up recombinant spider silk manufacturing
- Supports production for BAM-1 Alpha hybrid yarns and a recent apparel pilot order
Negative
- Land transfer described as pending; control depends on completion of transfer
- Company will deploy additional staffing and operational resources, implying higher near-term operating costs
News Market Reaction
On the day this news was published, KBLB declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
KBLB showed a modest +1.95% move while peers were mixed: GMGMF up 2.19%, NNOMF down 3.43%, ABSSF and BIOF slightly negative, GLGI near flat. This points to a stock‑specific reaction rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Mulberry land access | Positive | +0.0% | Secured government-owned mulberry gardens for spider silk expansion. |
| Nov 25 | Hiring expansion | Positive | +2.9% | Launched hiring to staff expanded Southeast Asia production footprint. |
| Nov 17 | Pilot customer order | Positive | +9.3% | Fulfilling customized spider silk yarn order for a global sports brand. |
| Nov 03 | Typhoon impact update | Positive | +0.3% | Confirmed no typhoon disruption after relocating production to highlands. |
| Oct 27 | Leadership promotion | Positive | +0.1% | Promoted Chief Scientist following breakthroughs in spider silk materials. |
Recent news has focused on production expansion, commercialization steps, and operational resilience, with prior positive updates often coinciding with flat to modestly positive price reactions.
Over the last few months, Kraig Biocraft Laboratories has reported a series of spider‑silk‑focused milestones. On Oct 27, it promoted Dr. Xiaoli Zhang to Chief Scientist after breakthroughs in next‑generation fibers. On Nov 3, it confirmed operations were unaffected by Southeast Asia typhoons due to prior relocations. Subsequent news on Nov 17 and Nov 25 highlighted a customized order for a performance sports brand and a hiring initiative for a new production center. Today’s Dec 8 land‑use announcement extends that expansion theme by securing feedstock capacity.
Market Pulse Summary
This announcement expands KBLB’s control over a key input by securing government-owned mulberry gardens near its Southeast Asia facilities. The move supports scaled production for recombinant spider silk, including BAM‑1 Alpha fibers tied to a pilot order from a performance sports brand. Against this operational progress, the latest 10‑Q showed $0 revenue, a quarterly net loss of $1,509,566, and a working capital deficiency of $8,544,784, so monitoring commercialization milestones and financing sources remains important.
Key Terms
recombinant spider silk medical
forward-looking statements regulatory
AI-generated analysis. Not financial advice.
ANN ARBOR, Mich., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of government-owned mulberry gardens located near its spider silk production operations in Southeast Asia.
These land-use rights, granted to Kraig Labs by a key government agency as part of the Company’s collaborative relationship, will play a central role in Kraig Labs' ongoing production expansion. The Company has agreed to pay a nominal rent for the use of the mulberry gardens. These mulberry gardens will provide the essential feedstock required to support the scaled-up of recombinant spider silk production. This added capacity will directly support the manufacturing of high-performance spider silk yarns targeted at performance textiles, technical apparel, and luxury fashion markets.
The newly secured acreage will provide a reliable and strategically positioned source of high-quality mulberry leaf, an essential input for maintaining production throughput and improved logistics. This alignment between land access, production capacity, and downstream processing is a key component of Kraig Labs' strategic expansion blueprint.
Today's announcement follows closely on the Company's recently announced order from a leading performance sports apparel brand. Kraig Labs is currently finalizing materials for this customer's pilot development program, which will utilize the Company's recombinant spider silk fibers. The addition of these mulberry gardens strengthens Kraig Labs' ability to meet future commercial demand as it advances toward broader market deployments.
"Access to these mulberry gardens marks another critical step in building an integrated and resilient production ecosystem for our spider silk technologies," said Kim Thompson, Founder and CEO of Kraig Biocraft Laboratories. "Securing direct access to high-quality mulberry acreage gives us greater control over our supply chain and positions us to accelerate production of our BAM-1 Alpha hybrid spider silk. This collaboration with government stakeholders reflects their confidence in the economic and technological potential of our work."
As this land is transferred to Kraig Labs' control, the Company will prepare the gardens for incorporation into its expanding spider silk production pipeline. Additional staffing and operational resources will be deployed as part of the integration process, supporting both near-term production increases and the Company's strategic vision for large-scale commercialization.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
FAQ
What did Kraig Biocraft Laboratories (KBLB) announce on December 8, 2025 about mulberry gardens?
How will the mulberry gardens affect KBLB's spider silk production capacity?
Will the mulberry gardens support any specific Kraig Labs product or program?
Does Kraig Labs (KBLB) own the mulberry gardens outright after the announcement?
Are there immediate costs or operational changes from integrating the mulberry gardens for KBLB?
